Myocardial blood flow and efficiency in concentric and eccentric left ventricular hypertrophy

American Journal of Hypertension

Volumn 17, Issue 5, 2004, Pages 433-438

  Akinboboye, Olakunle O ^a,d   Chou, Ru Ling ^b   Bergmann, Steven R ^b,c  

^a STONY BROOK UNIVERSITY   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c BETH ISRAEL MEDICAL CENTER   (United States)

^d ST FRANCIS HOSPITAL   (United States)

Author keywords

Left ventricular hypertrophy; Myocardial blood flow; Myocardial oxygen demand; Myocardial perfusion reserve; Positron emission tomography

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONCENTRIC LEFT VENTRICULAR HYPERTROPHY; CONTROLLED STUDY; ECCENTRIC LEFT VENTRICULAR HYPERTROPHY; FEMALE; HEART CONTRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE BLOOD FLOW; HEART MUSCLE OXYGEN CONSUMPTION; HEART SIZE; HUMAN; INTERMETHOD COMPARISON; MALE; MATHEMATICAL COMPUTING; MEASUREMENT; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; BLOOD PRESSURE; CORONARY CIRCULATION; DIPYRIDAMOLE; ECHOCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; MYOCARDIAL REPERFUSION; MYOCARDIUM; OXYGEN CONSUMPTION; REGIONAL BLOOD FLOW; STATISTICS; STROKE VOLUME; SYSTOLE; TOMOGRAPHY, EMISSION-COMPUTED; VASODILATOR AGENTS;

EID: 1942532821     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2004.02.006     Document Type: Article

References (29)

1. Koren M.J., Devereux R.B., Casale P.N. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 114:1991;345-352.
2. Levy D., Garrison R.J., Savage D.D., Kannel W.B., Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 322:1990;1561-1566.
3. Laine H., Katoh C., Luotolahti M., Yki-Jarvinen H., Kantola I., Jula A., Takala T.O., Ruotsalainen U., Iida H., Haaparanta M., Nuutila P., Knuuti J. Myocardial oxygen consumption is unchanged but efficiency is reduced in patients with essential hypertension and left ventricular hypertrophy. Circulation. 100:1999;2425-2430.
4. Akinboboye O.O., Chou R.L., Bergmann S.R. Augmentation of myocardial blood flow in hypertensive heart disease by angiotensin antagonists a comparison of lisinopril and losartan. J Am Coll Cardiol. 40:2002;703-709.
5. Akinboboye O.O., Idris O., Goldsmith R., Berekashvili K., Chou R.L., Bergman S.R. Positron emission tomography, echo-Doppler and exercise studies of functional capacity in hypertensive heart disease. Am J Hypertens. 15:2002;907-910.
6. Goldstein R.A., Haynie M. Limited myocardial perfusion reserve in patients with left ventricular hypertrophy. J Nucl Med. 31:1990;255-258.
7. Ghali J.K., Liao Y., Cooper R.S. Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease. J Am Coll Cardiol. 31:1998;1635-1640.
8. Schiller N.B., Shah P.M., Crawford M., De Maria A., Devereux R., Feigenbaum H., Gutgesell M., Reichek N., Sahn D., Schnittger I., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 2:1989;358.
9. Gaasch W.H. Left ventricular radius to wall thickness ratio. Am J Cardiol. 43:1979;1189.
10. de Simone G., Daniels S.R., Devereux R.B., Meyer R.A., Roman M.J., De Divitiis O., Alderman M.H. Left ventricular mass and body size in normotensive children and adults assessment of allometric relations and the impact of overweight. J Am Coll Cardiol. 20:1992;1251-1260.
11. Gopal A.S., King D.L., Katz J. Three-dimensional echocardiographic volume computation by polyhedral surface reconstruction in vitro validation and comparison to magnetic resonance imaging. J Am Soc Echocardiogr. 5:1992;115-124.
12. Gopal A.S., Keller A.M., Shen Z., Sapin P.M., Schroeder K.M., King D.L. Jr, King D.L. Three-dimensional echocardiography in vitro and in vivo validation of left ventricular mass and comparison with conventional echocardiography methods. J Am Coll Cardiol. 24:1994;514-516.
13. Armbrecht J.J., Buxton D.B., Brunken R.C., Phelps M.E., Schelbert H.R. Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C]acetate and dynamic positron tomography. Circulation. 80:1989;863-872.
14. Henes G.C., Bergmann S.R., Walsh M.N., Sobel B.E., Geltman E.M. Assessment of myocardial oxidative metabolic reserve with positron emission tomography and carbon-11 acetate. J Nucl Med. 30:1989;1489-1499.
15. Akinboboye O., Bergmann S.R. Use of carbon 11-acetate for the measurement of myocardial oxygen consumption. J Nucl Cardiol. 7:2000;282-285.
16. Brown M.A., Myears D.W., Bergmann S.R. Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization. J Nucl Med. 30:1989;187-193.
17. Walsh M.N., Geltman E.M., Brown M.A., Henes C.G., Weinheimer C.J., Sobel B.E., Bergmann S.R. Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-11 acetate in patients with myocardial infarction. J Nucl Med. 30:1989;1798-1808.
18. Beanlands B.S.B., Bach D.S., Raylman R., Armstrong W.F., Wilson V., Montieth M., Moore C.K., Bates E., Schwaiger M. Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy. J Am Coll Cardiol. 22:1993;1389-1398.
19. Bergmann S.R., Herrero P., Markham J., Weinheimer C.J., Walsh M.N. Non-invasive quantitation of myocardial blood flow in human subjects with oxygen-15 labeled water and positron emission tomography. J Am Coll Cardiol. 14:1989;639.
20. Strauer B.E. Ventricular function and coronary hemodynamics in hypertensive heart disease. Am J Cardiol. 44:1979;999-1006.
21. Brush J.E., Cannon R.O. III, Schenke W.H., Bonow R.O., Leon M.B., Maron B.J., Epstein S.E. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med. 319:1988;1302-1307.
22. Marcus M.L., Chilian W.M., Kanatsuka H., Dellsperger K.C., Eastham C.L., Lamping K.G. Understanding the coronary circulation through studies at the microvascular level. Circulation. 82:1990;1-7.
23. Schwartzkopff B., Motz W., Frenzel H., Vogt M., Knauer S., Strauer B.E. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation. 88:1993;993-1003.
24. Nitenberg A., Antony I., Loiseau A. Left ventricular contractile performance, ventriculoarterial coupling, and left ventricular efficiency in hypertensive patients with left ventricular hypertrophy. Am J Hypertens. 11:1998;1188-1198.
25. Huysman J.A.N., Vliegen H.W., Vanderlasse A., Eulderink F. Changes in nonmyocyte tissue composition associated with pressure overload of hypertrophied human hearts. Pathol Res Pract. 184:1989;577-581.
26. Bartosova D., Chvapil M., Korecky B., Poupa O., Rakusan K., Turek Z., Vizek M. The growth of the muscular and collagenous parts of the rat heart in various forms of cardiomegaly. J Physiol (Lond). 200:1969;285-295.
27. Taegtmeyer H, Razeghi P, Young ME: Mitochondrial proteins in hypertrophy and atrophy: a transcript analysis in rat heart. Clin Exp Pharmacol Physiol 2002;29:346-350
28. Liao Y., Cooper R.S., Mensah G.A., McGee D.L. Left ventricular hypertrophy has a greater impact on survival in women than in men. Circulation. 92:1995;805-810.
29. Brilla C.G., Janicki J.S., Weber K.T. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation. 83:1991;1771-1779.